2018 AAHA Diabetes Management Guidelines for Dogs and Cats.
Behrend E, Holford A, Lathan P, Rucinsky R, Schulman R.
J Am Anim Hosp Assoc. 2018 Jan/Feb;54(1):1-21. doi: 10.5326/JAAHA-MS-6822.
Rosiglitazone.
Balfour JA, Plosker GL.
Drugs. 1999 Jun;57(6):921-30; discussion 931-2. doi: 10.2165/00003495-199957060-00007.
Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
Ling J, Ng JKC, Chan JCN, Chow E.
Front Endocrinol (Lausanne). 2022 Apr 22;13:869899. doi: 10.3389/fendo.2022.869899. eCollection 2022.
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial.
Philis-Tsimikas A, Bergenstal RM, Bailey TS, Jinnouchi H, Thrasher JR, Ilag L, Mitra J, Syring K, Threlkeld RJ.
Lancet. 2025 Jun 28;405(10497):2279-2289. doi: 10.1016/S0140-6736(25)01044-X. Epub 2025 Jun 22.
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial.
Blevins T, Dahl D, Pérez Manghi FC, Murthy S, Ortiz Carrasquillo R, Li X, Chang AM, Carr MC, Katz M.
Lancet. 2025 Jun 28;405(10497):2290-2301. doi: 10.1016/S0140-6736(25)01069-4. Epub 2025 Jun 22.
Systematic review of guideline recommendations for older and frail adults with type 2 diabetes mellitus.
Bolt J, Carvalho V, Lin K, Lee SJ, Inglis C.
Age Ageing. 2024 Nov 1;53(11):afae259. doi: 10.1093/ageing/afae259.
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity.
Volčanšek Š, Koceva A, Jensterle M, Janež A, Muzurović E.
Diabetes Ther. 2025 Jun;16(6):1207-1227. doi: 10.1007/s13300-025-01733-8. Epub 2025 May 7.
Non-insulin treatments for diabetes.
Angueira E.
Am J Ther. 2013 Jul-Aug;20(4):377-84. doi: 10.1097/MJT.0b013e318235f2cb.
Repaglinide.
Balfour JA, Faulds D.
Drugs Aging. 1998 Aug;13(2):173-80. doi: 10.2165/00002512-199813020-00008.
Nateglinide.
Dunn CJ, Faulds D.
Drugs. 2000 Sep;60(3):607-615; discussion 616-7. doi: 10.2165/00003495-200060030-00007.
